Welcome to our dedicated page for Nature’S Sun SEC filings (Ticker: NATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. SEC filings for Nature’s Sunshine Products, Inc. (NASDAQ: NATR), a natural health and wellness company that manufactures and distributes herbal, nutritional and personal care products. As a registrant on the Nasdaq Capital Market, Nature’s Sunshine files periodic and current reports that describe its operations, financial condition, risk factors and material corporate events.
Through this filings feed, readers can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include segment information for Asia, Europe, North America and Latin America & Other, along with discussions of gross margins, selling, general and administrative expenses, adjusted EBITDA and the impact of foreign currency. These reports also incorporate detailed risk factor disclosures related to government regulation, direct selling, independent consultants, product liability, supply chain disruptions, cybersecurity, data privacy and tax matters.
Nature’s Sunshine also uses current reports on Form 8-K to announce material events. Recent 8-K filings have covered quarterly financial results, executive leadership changes such as the appointment of a new Chief Executive Officer, secondary public offerings by a selling stockholder, share repurchase agreements, and share purchase agreements to acquire interests in joint ventures in Hong Kong and Shanghai. These filings often reference non-GAAP measures and include reconciliations in attached exhibits.
Investors can also monitor registration statements and prospectus supplements related to offerings of common stock, as well as agreements tied to concurrent share repurchases. Where applicable, Form 4 and other insider transaction reports provide additional insight into trading activity by directors and officers.
On Stock Titan, AI-powered tools summarize lengthy filings, highlight key changes from prior periods and surface important items such as segment performance, capital allocation decisions, material contracts and governance updates. Real-time ingestion from EDGAR helps ensure that new NATR filings, including 10-Ks, 10-Qs, 8-Ks and ownership reports, are available quickly with plain-language explanations to support deeper research into Nature’s Sunshine’s regulatory and financial disclosures.
Nature's Sunshine Products, Inc. is asking shareholders to vote at its 2026 annual meeting on four items: electing eight directors, approving an advisory say-on-pay resolution, ratifying Deloitte & Touche as auditor, and approving a new 2026 Stock Incentive Plan.
The company reports 2025 net sales of $480.1 million, up 2.7% from 2024, and net income of $20.5 million. Executive pay is positioned as pay-for-performance, with significant use of restricted stock units and performance-based RSUs tied to adjusted EBITDA growth and relative total shareholder return. The board is majority independent, with separate Chair and CEO roles and fully independent Audit and Compensation Committees.
Natures Sunshine Products reported that Global Chief Marketing Officer Kevin Gregory Fuller had a prior grant of 7,965 restricted stock units dated March 6, 2026, scheduled to vest in three equal annual installments through March 6, 2029. On March 24, 2026, the company rescinded and cancelled all of these units before any vested. Following this update, Fuller holds 21,460 common shares directly, with no open-market purchases or sales disclosed.
Natures Sunshine Products Inc executive vice president of global supply chain Erich A. Fritz reported an administrative equity adjustment. On March 6, 2026, he was granted 8,180 restricted stock units that were later rescinded and cancelled on March 24, 2026, before any vesting occurred. Following this adjustment, he directly held 10,760 common shares.
Natures Sunshine Products disclosed a compensation-related equity change for Chief Executive Officer Kenneth G. Romanzi. On March 6, 2026, he was granted 29,928 restricted stock units, scheduled to vest in three equal annual installments through March 6, 2029. On March 24, 2026, the company rescinded and cancelled all 29,928 units before any had vested. Following these transactions, Romanzi directly holds 102,881 common shares.
Natures Sunshine Products executive Bryant J. Yates reported an administrative change to his equity awards. On March 6, 2026, he was granted 7,761 restricted stock units that were scheduled to vest in three equal annual installments through March 6, 2029. The company later rescinded and cancelled all 7,761 units on March 24, 2026, before any had vested. Following this update, Yates directly holds 77,393 common shares.
NATURES SUNSHINE PRODUCTS INC reported an administrative change to equity compensation for executive Daniel C. Norman, EVP & President, Asia. On March 6, 2026, the company granted him 10,088 restricted stock units that were scheduled to vest in three equal annual installments through March 6, 2029.
On March 24, 2026, the company rescinded and cancelled all 10,088 restricted stock units before any had vested. Following this adjustment, Norman’s reported direct holding stands at 41,995 common shares. The Form 4 reflects this as an “other” type of transaction rather than a buy or sell in the open market.
NATURES SUNSHINE PRODUCTS INC reported an administrative equity compensation change for its SVP and Chief Accounting Officer, Jonathan David Lanoy. On March 6, 2026, the company granted 5,415 restricted stock units scheduled to vest in three equal annual installments through March 6, 2029. On March 24, 2026, the company rescinded and cancelled all 5,415 units, and none had vested before cancellation. Following this activity, Lanoy directly holds 40,990 common shares.
Nature’s Sunshine Products Inc. reported an administrative equity change for EVP & Chief Financial Officer Leslie Shane Jones. On March 6, 2026, the company granted 11,798 restricted stock units that were scheduled to vest in three equal annual installments through March 6, 2029. On March 24, 2026, the company rescinded and cancelled all of these units before any had vested. Following this non-market restructuring, Jones directly held 104,528 common shares.
NATURES SUNSHINE PRODUCTS INC reported an administrative change in equity compensation for EVP & President, North America, Herbert Kevin R. The company granted 7,124 restricted stock units on March 6, 2026, scheduled to vest in three equal annual installments through March 6, 2029. On March 24, 2026, the company rescinded and cancelled all 7,124 units before any had vested, so this did not result in vested equity or cash proceeds and reflects a non-market, restructuring-type adjustment to his compensation.
NATURES SUNSHINE PRODUCTS INC reported a compensation adjustment for EVP and General Counsel Nathan G. Brower. On March 6, 2026, the company granted him 7,250 restricted stock units scheduled to vest in three equal annual installments through March 6, 2029. On March 24, 2026, the company rescinded and cancelled all 7,250 units before any had vested. Following these changes, Brower directly holds 43,634 common shares.